MERSANA THERAPEUTICS

Mersana Therapeutics to Present at the Upcoming Stifel 2021 Virtual Healthcare Conference

10 11 2021 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update

09 11 2021 05:00:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Host Conference Call Announcing Third Quarter 2021 Financial Results and Business Updates

02 11 2021 07:00:02 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

27 10 2021 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Appointment of Mohan Bala, Ph.D., as SVP, Strategic Product Planning & Program Leadership

25 10 2021 07:00:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Target and Presents New Preclinical Data for XMT-2056, First Immunosynthen STING-Agonist ADC, at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

07 10 2021 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Announce Target and Present New Preclinical Data for XMT-2056 at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

30 9 2021 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Upcoming Investor Conferences

07 9 2021 07:00:03 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 8 2021 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Appointment of Tushar Misra, Ph.D., as Chief Manufacturing Officer

16 8 2021 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update

06 8 2021 05:00:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at the 12th Annual Wedbush PacGrow Healthcare Conference

04 8 2021 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Host Conference Call Announcing Second Quarter 2021 Financial Results and Business Updates

30 7 2021 07:00:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Initiation of the UPGRADE Phase 1 Platinum Combination Cohort for UpRi in Platinum-Sensitive Ovarian Cancer

28 7 2021 07:00:02 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Jefferies Virtual Healthcare Conference

26 5 2021 07:00:02 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update

10 5 2021 15:01:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Host Conference Call Announcing First Quarter 2021 Financial Results and Business Updates

03 5 2021 07:00:02 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

28 4 2021 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Appointment of Alejandra Carvajal as Senior Vice President and Chief Legal Officer

26 4 2021 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT-1660 in Three Posters at Virtual 2021 AACR Annual Meeting

10 4 2021 08:00:00 提供 Nasdaq GlobeNewswire